Purpose To describe survivorship services provided by the Children's Oncology Group (COG), an assessment of services was undertaken. Our overall aims were (1) to describe survivorship services, including the extent of services provided, resources (personnel, philanthropy, and research funding), billing practices, and barriers to care and 2) to describe models of care that are in use for childhood cancer survivors and adult survivors of childhood cancer. Methods One hundred seventy-nine of 220 COG institutions (81%) completed an Internet survey in 2007. Results One hundred fifty-five (87%) reported providing survivorship care. Fifty-nine percent of institutions provide care for their pediatric population in specialized late effects programs. For adult survivors, 47% of institutions chose models of care, which included transitioning to adult providers for risk-based health care, while 44% of institutions keep survivors indefinitely at the treating institution (Cancer Center Based Model without Community Referral). Sixty-eight percent provide survivors with a copy of their survivorship care plan. Only 31% of institutions provide a detailed summary of results after each clinic visit, and 41% have a database to track survivor health outcomes. Minimal time required for initial and annual survivorship visits is estimated to be approximately 120 and 90 min, respectively. The most prevalent barriers to care were the lack of dedicated time for program development and a perceived insufficient knowledge on the part of the clinician receiving the transition referral.
Introduction
Advances in the treatment of childhood cancer, improved supportive care strategies, enhanced diagnostic testing, and enrollment on clinical trials over several decades have contributed to a growing number of cancer survivors. As a result, children are surviving their diseases such that there is an estimated 5-year survival rate of 80% [1] and an estimated 300,000 cancer survivors in the USA [2, 3] . Two thirds of survivors may exhibit some late effect of their therapy [4, 5] . These late effects may be mild to severe and include multiple physical and psychosocial health care problems, such as changes in physical appearance, organ dysfunction, infertility, neurocognitive impairments, cardiotoxicity, second neoplasms, endocrinopathies, musculoskeletal dysfunction, and challenges in social relationships .
Despite hope that more contemporary protocols may reduce the frequency and severity of late effects, lifelong risk-based care is recommended for childhood cancer survivors (CCS). Health care transition during young adulthood from pediatric to adult-oriented providers has been advocated as a means of continuing appropriate monitoring and management of late effects across the lifespan [33, 34] . However, the best clinical practices, models of survivorship care, costs of providing survivorship care, and transitioning practices linked to maximizing health care outcomes have not been fully delineated or evaluated. The Institute of Medicine and leaders in cancer survivorship have recommended that pediatric oncology begins the process of examining and evaluating services for survivors [2] . A first step in this process has been accomplished through general recommendations and via the development of several guidelines [35] [36] [37] [38] , which provide the foundation for further assessment of outcomes based on treatment exposures.
Our aims were (1) to describe survivorship services, including the extent of services provided, resources (personnel, philanthropy, and research funding), billing practices, and barriers to care and (2) to describe models of care that are in use for childhood cancer survivors and adult survivors of childhood cancer. Specifically included in this survey were questions assessing health care transition practices for young adult survivors, given the emerging importance of that issue as this population ages.
Methods
A 67-item online survey using Zoomerang TM (see Appendix A) was developed. The online survey asked about survivorship services, including the extent of services provided, program size, and resources (including personnel, philanthropy, and research funding), billing practices, and perceived barriers to care. Additional information was ascertained to describe survivorship services and models of care utilized for adult survivors of childhood cancer. Email announcements and introductory letters about the survey were sent over a 6-month timeframe in 2007 to existing COG member institutions in good and provisional standing via COG principal investigators (PIs), nursing responsible investigators (RIs), and clinical research associates (CRAs). Institutions were informed that survey responses would be reported collectively for the COG, not individually. One set of responses per institution was requested. Participants were allowed to skip questions at their discretion, and, in the case of multiple responses from institutions, the most complete set of responses was used. Responses to open-ended questions were tabulated into frequency distributions by two study investigators and grouped into themes and coded. Where coding varied, the study team shared findings and came to agreement for coding [39] .
Results

Survivorship services in COG institutions
One hundred seventy-nine (81%) of 220 COG member institutions completed the online survey. Eighty-seven percent reported providing late effect (LE) services to survivors, while 13% of institutions reported that they did not. For those institutions that did not provide LE services, no further information was obtained.
Fifty-nine percent of institutions that offer care to cancer survivors reported providing that care in a specialized LE program by a designated LE provider, 23% in regular oncology clinic by a survivor's treating oncologist, 16% in oncology clinic by a health care provider staffing clinic that day, and a small number (2%) were beginning survivorship programs or using various combinations of health care providers when delivering care. Twenty-five institutions (14%) did not answer this question.
Questions were asked about selected subgroups of survivors, categorized as stem cell transplant survivors (SCTS), central nervous system survivors (CNSS), and survivors of nononcologic conditions (e.g., those who may have received chemotherapy or irradiation for treatment of histiocytosis) in order to further define services for these groups. These survivors were eligible for late effects services in 94%, 97%, and 84% of institutions, respectively. Eligibility criteria for entry into LE services for these selected subgroups varied widely. Some criteria were time dependent, some were protocol or diagnosis specific, some were dependent on current clinical status (i.e., no graft vs. host disease), and other criteria were dependent on the discretion of the treating physician.
Additional information about services for survivors who were not originally treated at each responding institution was ascertained. Eighty-eight percent of responding institutions provide clinical consultations to survivors originally treated at other institutions, and more than half (55%) do not offer consultation by phone. Patients can self-refer for LE services in 83% of institutions.
Pediatric survivorship services
General practices
Routines for pediatric cancer survivors Fifty percent of participants reported that survivors come to the LE clinic and are referred to specialists at alternate times. Thirty-five percent reported that survivors are seen by their general oncologist who manages their survivorship care and are referred to specialists at alternate times. Eight percent reported that survivors come to the clinic staffed by the LE team and required specialists, and 6% reported various combinations of the aforementioned responses. Sixty-seven percent of participants reported that risk-based screening (e.g., echocardiogram, bone density test), if indicated, would be done at the same LE clinic visit, while 33% reported that it would be scheduled on another day time.
Patient educational materials Sixty-eight percent of participants reported that they provide survivors a copy of their survivorship care plan (SCP)/oncology treatment exposure summary, while 32% did not. Sixty-nine percent of participants reported that they did not provide written documentation about results to survivors after each visit.
Average time for survivor-related services
Information was collected about the average amount of time health care personnel spend per survivor for (1) preparation of SCP, (2) scheduling of tests, (3) clinical "face to face" time for an initial visit, (4) clinical "face to face" time spent in annual visits, (5) gathering, interpreting, and compiling results, (6) post-clinic conferencing, and (7) communication of results. These data were collected in time interval ranges expressed in minutes (<15, 15-30, 31-60, 61-90, 91-120, and >120 min). Estimates were calculated for the minimum amount of time required to complete various activities related to a scheduled survivor evaluation (pre-clinic preparation, direct contact time, and post-clinic management) for both initial and annual visits. Each initial visit includes the preparation of the SCP and is estimated to require at least 122 min. Each annual visit (without preparation of the survivorship care plan) was calculated to require about 91 min.
Adult survivorship services
Given the large number of survivors now entering adulthood we inquired "At what age (if applicable) are CCS referred outside the treating/pediatric center?" Out of 156 responses, 35% see adult survivors indefinitely at the treating institution and do not carry out transition elsewhere for continuation of risk-based care. Another 31% transition CCS when the survivor is ready, while others keep them to age 18 (5%), 21 (17%), 25 (4%), or 30 years old (1%).
For institutions reporting ≤50 survivorship visits annually, 67% continue seeing their adult patient indefinitely, whereas this is true for only about one third of larger programs. For medium-sized programs seeing 50-100 survivors per year, 26% send them to adult oncologists in an adult cancer center setting and 18% send them to their primary care provider. For larger programs seeing >100 survivors per year, the favored plan was to refer the adults to their primary care providers (approximately 30%).
To better understand which models are in use for adult survivor care, four recognized models were described (Table 1) , and participants were asked to select from one of these or further describe their own [40] . The most commonly chosen model provided by 44% of the 161 participants was the "Cancer Center-based Model WITH-OUT Community Referral." This model has been described as a model where survivors are kept indefinitely at the treating institution for their cancer-related/late effects (LE) follow-up care. Generally care is with the same late effects or oncology clinicians who provide care to the pediatric survivor population. When examining the type of model utilized by institutional size, we found that in medium sized institutions (101-500 survivor visits/year), the four models were utilized in approximately equal proportions, whereas in the smallest and largest institutions, the predominant model was the Cancer Center Based Without Community Referral.
Barriers to care for pediatric and adult survivors
We asked participants to review a list of common barriers to (1) providing optimal long term follow up care and (2) transition, as previously described in the literature for pediatric and adult CCS. Participants were asked to select the three most common barriers in their institution. The most frequently chosen barriers are reported in Tables 2 and 3 .
Survivorship databases
Less than half of the institutions (41%) reported having a database that was used to track survivors' clinical health care outcomes or other pertinent clinical information. The databases that were used included ACCESS (49%), Excel (15%), ONCOLOG (7%), institutionally devised/proprietary (7%), and OTHER responses (e.g., web-based, tumorregistry-assisted databases, Optex, Pediatric Oncology Group of Ontario network databases) (22%).
Financial issues and support
Billing practices
We collected information about billing practices according to Current Procedural Terminology (CPT) codes [41] . Seventeen percent of institutions did not respond to this question, and of those who did respond, 10% reported that they did not know their billing practices. Most US institutions bill at level 4/moderate complexity decision making (CPT 99214) or level 5/high complexity decision making (CPT 99215). The remainder of the billing practices is reflected in Table 4 .
Financial support of program operations/activities
About half (51%) of institutions reported some level of institutional/hospital support, such as salary funding. Institutions provided information about the availability (in the previous five calendar years) of philanthropic funding for support of LE personnel salaries and clinical care. Philanthropic funding was available but limited. It included salary support in about one third of institutions, while 19% 
Survivorship clinic personnel
Information was ascertained about various personnel known to be a part of survivorship programs or survivorship clinics. Specifically, we asked about the number of personnel in a particular role, not in full time equivalents for each role, including nurse practitioners, physician assistants, nurse coordinators, social workers, administrative support staff, clinical research associates, nutritionists/dieticians, and neuropsychologists/educational specialists. Seventy-two percent of institutions have at least one nurse practitioner, 53% have a nurse coordinator, 87% have a social worker, 49% have a nutritionist/dietician, and 74% have a neuropsychologist/ education specialist. Additionally three quarters of survivorship programs had a clinical research associate, and 72% had administrative support staff/secretarial support. Physician assistants were rarely utilized (5%). Thirty-nine percent of institutions reported that they provided dedicated personnel to solve insurance and /or employment related issues. Generally speaking, there was no clear association with institutional size and availability of these personnel.
Discussion
Survivorship services are expanding, and institutions are moving closer to reaching the goals set forth in the Institute of Medicine's report [2] . Although the field of cancer survivorship and survivor outcome research is rapidly evolving, data about survivor programs have been slower to develop. Until recently, only a few studies have addressed the availability of programs or services for survivors [42] [43] [44] [45] [46] [47] [48] , [48] . In our study, 97% of CNSS were eligible for survivorship services, lending further support that this subgroup has access to LE specialists. A recent study reports that there are approximately 300,000 CCS in the USA [3] , and many may be lacking risk-based care. Recognizing that only a subset of this population is receiving risk-based care, we asked participants to quantify the total number of survivors eligible for a risk-based visit in the previous calendar year. If each institution participating in our study provided care for this entire population of approximately 300,000 survivors, then we estimate that each institution in our study would be accountable for the follow-up of some 2,000 survivors, in either direct care or through referral and transition to community providers. We asked participants to quantify the number of survivors they felt were eligible for LE services at their institution. Our participants had difficulty quantifying a number of eligible survivors in a blank response box, or in many cases used descriptive terms to describe the potential survivorship number, such as "greater than," "approximately," "about," and "unknown." This made the total number of survivors eligible for a survivorship visit uninterpretable. Of note, few participants identified quantities of >1000 survivors, so we conclude that only a small subset of the eligible survivor pool have their risk-based long-term care coordinated by institutions within the COG. This conclusion supports previously described findings, which suggest that a large number of CCS do not receive recommended risk-based care [49] .
Transition to adult services
With an ever-growing number of survivors that challenge the capacity for their care [34, 50] , institutions face the challenge of how to provide the "best" risk-based care in a time of competing resources, reduction in resources, and lack of trained and experienced providers. Care that is longitudinal, risk based, shared, and encompasses formal transition to the adult setting has been advocated by many late effects clinicians, health care policy experts, and survivors [2, 34, 35, 40, [50] [51] [52] [53] [54] [55] [56] [57] [58] . Our data support recently published data [47] that survivors in some COG institutions are being transitioned outside of the catchment area of pediatric oncology for their continuing risk-based care. Formal transition of survivors to adult primary care providers with reciprocal and informative communication has been speculated to be rare [51] , challenging [47] , influenced by multiple barriers [34, 53, [59] [60] [61] , and necessary [34] Although our study did not assess methods for facilitating transition nor did it evaluate communication strategies when transitioning, our data reveal that transitioning survivors to adult providers is occurring to varying degrees within COG. Literature on transitioning children and adolescents with other chronic diseases continues to emerge and may be informative to pediatric oncology in the future [62] [63] [64] [65] [66] [67] [68] [69] [70] .
Various models for risk-based care for adult survivors of pediatric cancers have been reported in the literature. When asked to choose a specific model for adult survivors, the single most popular choice was the Cancer-Based Model Without Community Referral, the model where survivors are kept indefinitely at the treating institution for their risk-based care (44%). However, if one considers that three of the other models provided as choices (except for the postal/internet/ phone based model), each included transitioning of survivors outside the realm of pediatric oncology in some capacity, such as to primary care physicians (21%), to adult health providers in the same health care system (24%), or to adult oncologists (2%), then an additional conclusion can be drawn. Cumulatively, it appears that almost equal numbers of COG institutions are transitioning adult survivors to adult providers (47%) as are keeping adult survivors indefinitely at the their institution (44%). Our findings support the work of others who have reported that a multitude of institutional, provider, and individual survivor circumstances influence the methods by which adult survivors are systematically followed. In the current study, we have not explored exactly how this care is provided or how carefully this care is planned and executed. Our data indicate there is no single approach that is utilized universally. We recommend an evaluation of specific components of transitional care services as well as studies of methods to address the problem of survivor follow-up attrition [34, 71] .
In our study, the top three barriers to providing care for pediatric survivors and for successful transition for adult survivors were consistent with barriers previously reported [53, 72] and underscore the importance of educating survivors and future providers, especially primary care providers, about late effects of cancer treatment.
Approximately two thirds of institutions reported providing survivors with a copy of their SCP. This is far less than would be expected since this practice that has become commonplace in survivorship programs. It is hoped that our data underestimate current practice and reflect the time of the survey (2007). Survivorship care plans may facilitate survivor knowledge about treatment-related exposures and include important health information that may be used to guide systematic follow-up according to the Children's Oncology Group (COG) Long-Term Follow-up Guidelines for Childhood, Adolescent, and Young Adult Cancers [35] . The SCP can function as a communication tool for other clinicians to be knowledgeable about past exposures, and it can be useful in the event of a significant adverse event or when clinical decisions need to be made. Unfortunately, the additional provision of written documentation about pertinent findings after each survivor's health-related visit is lacking in most COG institutions (69%) and would be an area for improvement, especially in light of reported survivor knowledge deficits [73] and the perceived barrier of lack of clinician knowledge about late effects. The lack of databases for documentation of health outcomes and clinical information potentially compromises easy accessibility to survivorship data useful for research initiatives. Perhaps, a goal for the future preparation of SCP is for documentation to begin when therapy starts, especially for patients with anticipated good prognoses. If a list of exposures is compiled early, utilizing state-of-the-art database technologies or electronic medical records, it could ease the transition to survivorship care by saving time for those abstracting medical records. Passport to Care, developed by the Baylor College of Medicine and the Children's Oncology Group, is an example of an online resource designed to provide a readily accessible record of cancer treatment and associated individualized exposurerelated recommendations [74] .
Costs involved in caring for survivors
When survivorship services were in their infancy, clinicians recognized that more time would be required for a comprehensive survivorship examination as compared to a routine oncology visit. In an early study, leukemia survivors required an average of 52 min of provider time, as compared to 37 min for the other oncology patients [75] . Our data further support that survivor care is time intensive. Our time estimations were calculated for the minimum amount of time required by at least two thirds of institutions for completion of activities related to a survivor's evaluation (initial and annual visit), which includes pre-clinic preparation, direct contact time, and post-clinic management. Therefore, our estimations of time spent for various survivor-related activities were based on conservative assumptions and are an underestimate of time spent. Our time estimations should be improved by newer computerized charting systems and advanced information technologies currently employed by many COG institutions. Promotion of optimal health outcomes in a time-efficient, cost-effective manner is necessary. Furthermore, knowledge of current billing practices as elucidated by this study needs to be coupled with more information derived from research regarding reimbursement patterns.
Limitations
Our study provides initial data about survivorship services that was easily attainable via a web-based survey. Limitations of the study are those inherent to survey-based research. Although we sought to target health care professionals who were most knowledgeable about LE services to provide a single institutional response, we recognize that responses were subjective and based on the individual participant knowledge. Not all questions were answered by all participants. In future surveys, we recommend shorter, targeted surveys with enhanced skip logic so that participants do not become fatigued, and inclusion of a status of completion bar so that participants can track their time to completion of the survey.
Implications for cancer survivors
Survivorship services are important because they improve early detection, enable preventative health care practices to modify risk, and enable improved physical and psychosocial care for CCS. Survivorship services are available in COG, including transition services, but best practices and models of care have not yet been fully defined. More research is vital for the evolution of survivorship care. Both survivors and future providers need to be educated about survivorship issues, health-related risks, health promotion behaviors, and early intervention strategies. Exploring ways to enhance this knowledge, evaluating strategies for effective teaching utilizing state of the art, cost effective technologies, and testing methods/models, which prevent survivor follow-up attrition would inform design of integrated and comprehensive transition models focused not only on the physical but the psychosocial needs of survivors. Finally, collaborative research with adult-focused providers and programs, utilizing survivor input, will be essential for defining and meeting the future needs of these young adult cancer survivors.
Appendix A. State of Late Effects (LE) Services in COG
1 Only one set of answers is needed for each institution in COG.
Before proceeding please check with others at your institution to determine if your institutional information has already been submitted.
The survey will take approximately 15-20 minutes to complete. You can come back to re-enter data at any time; however, the program will not "remember" where you left off, so you will need to start from the beginning. Therefore, it is advisable to complete the entire survey at one time.
2 Please choose your institution from the drop down menu provided.
If you are having difficulty finding your institution, please contactDebra Eshelman-Kent via e-mail at debra. kent@cchmc.org or Karen Kinahan at K-Kinahan@-northwestern.edu. We see our former pediatric cancer patients indefinitely at the treating institution and do not transition them elsewhere for their risk based care.
No age limitations, we transition survivors when survivor is ready.
Our survivors are seen through age 16, then transition elsewhere.
Our survivors are seen through age 18, then transition elsewhere.
Our survivors are seen through age 21, then transition elsewhere.
Other criteria: Please Describe. a) Lack of knowledge about late effects by the clinician being referred to b) Survivor lack of health care insurance or insurance limitations c) Survivor knowledge deficit about the importance of maintaining cancer related follow-up into adulthood d) Lack of survivor desire to leave the comfort of the treating institution or oncologist e) Lack of survivor access to a primary care provider for reasons other than insurance such as geography f) Lack of oncology provider desire to "let go" of survivor g) Conflict between COG recommendations for risk based follow-up and adult health care provider recommendations h) We do not have any barriers i) Other, please specify 68 Please describe any unique features about your LE follow-up that you feel have not been previously addressed (limit to 500 characters)
